Directors' Dealings

7 November 2012

DDD GROUP PLC

Directors' Dealings

DDD Group plc (AIM: DDD, the "Company"), the 3D solutions company, announces that on 5 November 2012 Dr. Sanji Arisawa and Mr. Warren Littlefield expressed their intent to exercise options from the April 2008 grant which are set to expire in April 2013.

Dr. Arisawa and Mr. Littlefield have each exercised options over 200,000 ordinary shares of 1p each in the Company (the "Ordinary Shares") at an exercise price of 10p per share (together the "Option Exercise").

Following the Option Exercise, Dr. Arisawa's personal interest in the Company stands at 1,889,200 Ordinary Shares or approximately 1.4% of the issued ordinary share capital and total voting rights in the Company. Dr. Arisawa has requested the sale of the shares that are being acquired through the Option Exercise. Dr. Arisawa is the Chairman of Arisawa Manufacturing Corporation Ltd. which currently owns 29,856,123 Ordinary Shares or 22.1% of the issued ordinary share capital and total voting rights.

Following the Option Exercise, Mr. Littlefield's personal interest in the Company stands at 665,000 Ordinary Shares or approximately 0.5% of the issued ordinary share capital and total voting rights in the Company.

Dr. Arisawa and Mr. Littlefield's shares are part of the block admission that was announced on 12 June 2012 and admitted to AIM on 18 June 2012.

For the purposes of Disclosure and Transparency Rules, following the Option Exercise the Company's total issued and admitted share capital is 134,828,812 Ordinary Shares. There are no Ordinary Shares held in treasury. The total number of voting rights in the Company will therefore be 134,828,812.

The above figure of 134,828,812 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

Enquiries